Leidos Holdings stock analysis
Leidos Holdings (S6IA) Stock Price & Analysis
S6IA Stock Chart & Stats
- Day’s Range
- EUR 121.10 - EUR 123.55
- 52-Week Range
- EUR 87.28 - EUR 170.95
- Previous Close
- EUR 123.35
- Volume
- N/A
- Average Volume (3M)
- 24
- Market Cap
- EUR 15.09B
- Enterprise Value
- EUR 20.56B
- Total Cash (Recent Filing)
- EUR 630.00M
- Total Debt (Recent Filing)
- EUR 6.56B
- Price to Earnings (P/E)
- 11.9
- Beta
- 0.51
- Next Earnings
- Feb 16, 2027 (Est.)
- EPS Estimate
- 2.43
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.24%
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Reliable conversion of earnings into cash strengthens Leidos’ ability to fund investment, support dividends and repurchases, and reduce reliance on external financing. The scale of cash generation also provides flexibility to pursue organic growth and strategic opportunities through the next several quarters.
Growing Backlog And Bookings
A book-to-bill ratio above one and expanding funded backlog improve revenue visibility for a contract-driven business. This supports steadier future workloads, validates customer demand, and gives Leidos a durable base from which to convert awards into revenue over coming periods.
Diversified Growth Opportunities
Broad performance outside Health reduces dependence on one portfolio area and shows that Leidos has multiple avenues for expansion. Defense technology, homeland security, energy and cyber initiatives can support longer-term growth while stronger operating income indicates improving execution and mix.
Bears Say
Health Segment And VBA Uncertainty
The VBA transition creates an ongoing source of revenue and margin uncertainty in Health, with the full-quarter impact expected in the fourth quarter. Until the recompete is resolved, work-share outcomes could materially affect the segment’s contribution and consolidated growth profile.
Leverage Remains Unclear
Debt remains material relative to available cash, and the conflicting leverage measures reduce confidence in the underlying balance-sheet trend. Although cash generation supports financial capacity, elevated obligations may constrain flexibility for investment, acquisitions or shareholder returns if operating conditions weaken.
Limited Near-term Earnings Growth
The absence of expected bottom-line growth in 2027 signals that portfolio transitions may offset expansion in Defense, Energy and other businesses. This can limit earnings compounding over the next several quarters and places greater importance on successful execution of the VBA transition.
S6IA FAQ
What was Leidos Holdings’s price range in the past 12 months?
What is Leidos Holdings’s market cap?
When is Leidos Holdings’s upcoming earnings report date?
How were Leidos Holdings’s earnings last quarter?
Is Leidos Holdings overvalued?
Does Leidos Holdings pay dividends?
What is Leidos Holdings’s EPS estimate?
How many shares outstanding does Leidos Holdings have?
What happened to Leidos Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Leidos Holdings?
What is the TipRanks Smart Score and how is it calculated?
Leidos Holdings Stock Smart Score
Company Description
Leidos Holdings
Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector. This division's offerings encompass advanced technology, large-scale systems integration, command and control platforms, sophisticated data analytics, logistics, robust cybersecurity defenses, and crucial intelligence analysis and operational support for critical missions. The Civil segment offers systems integration capabilities primarily to air navigation service providers, such as the Federal Aviation Administration (FAA). This involves critical programs like En Route Automation Modernization (ERAM), Advanced Technology Oceanic Procedure (ATOP), Time Based Flow Management (TBFM), Terminal Flight Data Management (TFDM), GEO-7, and Future Flight Services, as well as developing enterprise-wide information display systems. Additionally, this segment provides security detection and automation services. Its portfolio further extends to comprehensive information technology (IT) solutions, covering areas like cloud computing, mobility, application modernization, DevOps, data center operations, network upgrades, asset management, help desk support, and digital workplace enablement. Environmental, energy, and infrastructure services also fall under this division. Finally, the Health segment furnishes solutions to both federal and commercial clients globally, focusing on initiatives that promote human health and well-being. This includes services such as health information management, managed healthcare programs, digital transformation projects, and support for life sciences research and development. Leidos Holdings, Inc. was established in 1969 and is based out of Reston, Virginia.
- Sector
- Technology
- Industry
- Information Technology Services
- CEO
- Thomas A. Bell
- Employees
- 50,000
- Website
- www.leidos.com
- Address
- 1750 Presidents Street, Reston, VA, 20190, US
Leidos Holdings (S6IA) Earnings & Revenues
S6IA Company Deck
S6IA Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, supported by 4% revenue growth, 19% EPS growth, a 13.9% adjusted EBITDA margin, $476 million of quarterly free cash flow, improving book-to-bill, backlog growth and strong momentum in Defense, Homeland, Energy, cyber and AI. However, the Health segment's VBA-related contraction, uncertainty around the VBA recompete, expected fourth-quarter growth moderation and the statement that 2027 will not be a bottom-line growth year were meaningful concerns. Overall, the breadth of operational and pipeline strengths significantly outweighed the disclosed challenges.
View all DE:S6IA earnings summariesS6IA Net sales Breakdown
- 44.20% National Security & Digita
- 30.10% Health & Civil
- 13.52% Commercial & International
- 12.18% Defense Systems
S6IA Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 5 | 5 |
| Technical Analysis | 5 | 5 | 0 |
| Moving Averages | 7 | 0 | 5 |
